IBEX Technologies (IBT) Stock Price, News & Analysis C$0.88 -0.01 (-1.12%) (As of 12/8/2023 05:18 PM ET) Add Compare Share Share Today's RangeC$0.88▼C$0.9350-Day RangeC$0.82▼C$1.0452-Week RangeC$0.48▼C$1.20Volume32,000 shsAverage Volume26,932 shsMarket CapitalizationC$21.68 millionP/E Ratio5.87Dividend Yield3.11%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines About IBEX TechnologiesIBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.Read More IBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBT Stock News HeadlinesOctober 18, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc flat on Wednesday (IBT)October 6, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc flat on Thursday (IBT)December 10, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comSeptember 26, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc down on Thursday (IBT)August 3, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc up on Tuesday (IBT)June 15, 2023 | finance.yahoo.comIs IBEX Technologies Inc.'s (CVE:IBT) Recent Stock Performance Tethered To Its Strong Fundamentals?June 14, 2023 | baystreet.caMayfair Hits 52-Week High on NewsMay 23, 2023 | ca.finance.yahoo.comIBEX Technologies Inc. (IBT.V)December 10, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comMay 9, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc up on Friday (IBT)April 22, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc down on Friday (IBT)April 6, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc down on Wednesday (IBT)March 22, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of IBEX Technologies Inc. (CVE:IBT)January 23, 2023 | baystreet.caAg Growth, ATEX, IBEX at 52-Week HighsSeptember 14, 2022 | finance.yahoo.comIbex Technologies Inc (IBT.BE)January 5, 2022 | investing.comIBEX Technologies Inc (IBT)November 13, 2021 | yahoo.comBig Country 11-man high school football scores, schedules 2021November 13, 2021 | yahoo.comBig Country six-man high school football scores, schedules 2021February 25, 2021 | msn.comA Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Economic DataFebruary 16, 2021 | benzinga.comMid-Morning Market Update: Gold Down 1.6%; Socket Mobile Shares Surge HigherFebruary 8, 2021 | venturebeat.comDigital Owl emerges from stealth with AI that analyzes and summarizes medical recordsFebruary 3, 2021 | markets.businessinsider.comMid-Afternoon Market Update: Dow Gains 75 Points; GW Pharmaceuticals Shares Jump On Acquisition NewsFebruary 3, 2021 | markets.businessinsider.comMid-Day Market Update: Crude Oil Rises Over 2%; Vaxart Shares PlummetJanuary 27, 2021 | benzinga.comMid-Morning Market Update: Markets Open Lower; AT&T Beats Q4 EstimatesJanuary 13, 2021 | markets.businessinsider.comMid-Morning Market Update: Markets Slightly Higher; IHS Markit Profit Beats ViewsJanuary 11, 2021 | markets.businessinsider.comMid-Morning Market Update: Markets Open Lower; AZZ Earnings Top ViewsJanuary 7, 2021 | benzinga.comMid-Afternoon Market Update: Dow Rises 250 Points; 3D Systems Shares Spike HigherSee More Headlines Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2023Today12/10/2023Next Earnings (Estimated)12/21/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:IBT CUSIPN/A CIKN/A Webwww.ibex.ca Phone+1-514-3444004FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.15 Trailing P/E Ratio5.87 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.89 million Net Margins51.97% Pretax MarginN/A Return on Equity33.34% Return on Assets6.22% Debt Debt-to-Equity Ratio12.04 Current Ratio5.69 Quick Ratio4.93 Sales & Book Value Annual SalesC$7.49 million Price / Sales2.89 Cash FlowC$0.56 per share Price / Cash Flow1.56 Book ValueC$0.55 per share Price / Book1.60Miscellaneous Outstanding Shares24,640,000Free FloatN/AMarket CapC$21.68 million OptionableNot Optionable Beta0.02 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Paul Baehr (Age 80)President, CEO & Chairman Comp: $434.09kBelinda Franco C.A.CPA, CFO, VP of Finance & Administration and SecretaryMahendra Kumar PallapothuVice President of OperationsKey CompetitorsLiberty BiopharmaCVE:LTYDevonian Health GroupCVE:GSDSirona BiochemCVE:SBMCeaproCVE:CZOResverlogixTSE:RVXView All Competitors IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed in 2023? IBEX Technologies' stock was trading at C$0.80 on January 1st, 2023. Since then, IBT stock has increased by 10.0% and is now trading at C$0.88. View the best growth stocks for 2023 here. When is IBEX Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, December 21st 2023. View our IBT earnings forecast. How were IBEX Technologies' earnings last quarter? IBEX Technologies Inc. (CVE:IBT) released its earnings results on Thursday, November, 9th. The company reported $0.10 earnings per share (EPS) for the quarter. The firm had revenue of $1.75 million for the quarter. IBEX Technologies had a trailing twelve-month return on equity of 33.34% and a net margin of 51.97%. What other stocks do shareholders of IBEX Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE), Bank of Montreal (BMO), Antares Pharma (ATRS), Algonquin Power & Utilities (AQN) and AJA.AX (AJA). How do I buy shares of IBEX Technologies? Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:IBT) was last updated on 12/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.